Imaging of coronary atherosclerosis: intravascular ultrasound
HM Garcia-Garcia, MA Costa… - European heart …, 2010 - academic.oup.com
Atherosclerosis is the main cause of coronary heart disease, which is today the leading
cause of death worldwide and will continue to be the first in the world in 2030. In the …
cause of death worldwide and will continue to be the first in the world in 2030. In the …
IVUS-based imaging modalities for tissue characterization: similarities and differences
HM Garcìa-Garcìa, BD Gogas, PW Serruys… - The international journal …, 2011 - Springer
Gray-scale intravascular ultrasound (IVUS) is the modality that has been established as the
golden standard for in vivo imaging of the vessel wall of the coronary arteries. The use of …
golden standard for in vivo imaging of the vessel wall of the coronary arteries. The use of …
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
PW Serruys, JA Ormiston, Y Onuma, E Regar… - The Lancet, 2009 - thelancet.com
Background Drug-eluting metallic coronary stents predispose to late stent thrombosis,
prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair …
prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair …
Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?
Y Onuma, PW Serruys - Circulation, 2011 - Am Heart Assoc
Gruntzig in 1977 was a huge leap forward in cardiovascular medicine and undoubtedly will
always be remembered as a revolution in the field of revascularization. However, this …
always be remembered as a revolution in the field of revascularization. However, this …
Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents: Igaki-Tamai Stents
S Nishio, K Kosuga, K Igaki, M Okada, E Kyo, T Tsuji… - Circulation, 2012 - Am Heart Assoc
Background—The purpose of this study was to evaluate the long-term safety of the Igaki-
Tamai stent, the first-in-human fully biodegradable coronary stent made of poly-l-lactic acid …
Tamai stent, the first-in-human fully biodegradable coronary stent made of poly-l-lactic acid …
Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging
Optical coherence tomography (OCT) is rapidly becoming the method of choice for
assessing arterial wall pathology in vivo. Atherosclerotic plaques can be diagnosed with …
assessing arterial wall pathology in vivo. Atherosclerotic plaques can be diagnosed with …
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque …
Aims To analyse the vasoreactivity of a coronary segment, previously scaffolded by the
ABSORB bioresorbable vascular scaffold (BVS) device, in relationship to its intravascular …
ABSORB bioresorbable vascular scaffold (BVS) device, in relationship to its intravascular …
In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy
J Pu, GS Mintz, ES Brilakis, S Banerjee… - European heart …, 2012 - academic.oup.com
Aims To test the hypothesis that near-infrared spectroscopy (NIRS) combined with
intravascular ultrasound (IVUS) would provide novel information of human coronary plaque …
intravascular ultrasound (IVUS) would provide novel information of human coronary plaque …
In vivo assessment of high-risk coronary plaques at bifurcations with combined intravascular ultrasound and optical coherence tomography
Objectives: This study sought to evaluate the in vivo frequency and distribution of high-risk
plaques (ie, necrotic core rich) at bifurcations using a combined plaque assessment with …
plaques (ie, necrotic core rich) at bifurcations using a combined plaque assessment with …
Assessing bioresorbable coronary devices: methods and parameters
HM Garcia-Garcia, PW Serruys, CM Campos… - JACC: Cardiovascular …, 2014 - jacc.org
Bioresorbable vascular scaffolds (BRS) represent a novel approach to provide transient
vessel support to drug-delivery capability without the long-term limitations of metallic drug …
vessel support to drug-delivery capability without the long-term limitations of metallic drug …